A detailed history of Fortitude Family Office, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Fortitude Family Office, LLC holds 612 shares of NVO stock, worth $29,657. This represents 0.01% of its overall portfolio holdings.

Number of Shares
612
Previous 838 26.97%
Holding current value
$29,657
Previous $57.8 Million 41.29%
% of portfolio
0.01%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 17, 2025

SELL
$45.38 - $71.7 $10,255 - $16,204
-226 Reduced 26.97%
612 $34 Million
Q2 2025

Jul 14, 2025

BUY
$58.08 - $81.05 $1,974 - $2,755
34 Added 4.23%
838 $57.8 Million
Q1 2025

Apr 15, 2025

BUY
$69.3 - $90.95 $33,957 - $44,565
490 Added 156.05%
804 $55.8 Million
Q4 2023

Jan 12, 2024

BUY
$87.78 - $105.45 $27,562 - $33,111
314 New
314 $32.5 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $109B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Fortitude Family Office, LLC Portfolio

Follow Fortitude Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortitude Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortitude Family Office, LLC with notifications on news.